Per accedir als documents amb el text complet, si us plau, seguiu el següent enllaç: http://hdl.handle.net/2445/99562
dc.contributor.author | Vilajeliu, Alba |
---|---|
dc.contributor.author | Sequera, Víctor Guillermo |
dc.contributor.author | García-Basteiro, Alberto L. |
dc.contributor.author | Sicuri, Elisa |
dc.contributor.author | Aldea, Marta |
dc.contributor.author | Velasco, César |
dc.contributor.author | Bayas Rodríguez, José María |
dc.date | 2016-06-16T13:20:05Z |
dc.date | 2016-06-16T13:20:05Z |
dc.date | 2016-04-22 |
dc.date | 2016-06-13T16:00:00Z |
dc.identifier.citation | 2164-5515 |
dc.identifier.uri | http://hdl.handle.net/2445/99562 |
dc.format | 18 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Taylor & Francis |
dc.relation | Versió postprint del document publicat a: http://dx.doi.org/10.1080/21645515.2016.1168955 |
dc.relation | Human Vaccines & Immunotherapeutics, 2016 |
dc.relation | http://dx.doi.org/10.1080/21645515.2016.1168955 |
dc.rights | (c) Taylor & Francis, 2016 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Hepatitis B |
dc.subject | Malalties del ronyó |
dc.subject | Hepatitis B |
dc.subject | Kidney diseases |
dc.title | Immunogenicity and immunization costs of adjuvanted versus non-adjuvanted hepatitis B vaccine in chronic kidney disease patients |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/acceptedVersion |
dc.description.abstract |